Slightly more balanced article from SMH
disallowed/business/small-business/troubled-mesoblast-secures-crucial-cash-buffer-from-surprise-us-backer-20210302-p5770h.html
"Troubled drug developer Mesoblast has been given a financial lifeline analysts expect will give it an 18-month cash buffer after securing a $138 million investment from a surprise US backer.
The ASX-listed $1.45 billion stem cell treatments maker unveiled an unexpected new partner on Tuesday, confirming it had sealed a $US110 million ($138 million) deal with a US investor group led by surgery clinics business, SurgCenter Development."
Cell Therapy News/Articles, page-8445
-
- There are more pages in this discussion • 9,984 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |